13D/13G Filings - Arcturus Therapeutics Holdings Inc. (ARCT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-02
3:13 pm
Purchase
2020-12-31 13G Arcturus Therapeutics Holdings Inc.
ARCT
BlackRock Inc.
BLK
1,781,955
6.900%
1,781,955increase
(New Position)
Filing
History
2021-01-08
2:00 pm
Purchase
2020-12-31 13G Arcturus Therapeutics Holdings Inc.
ARCT
FEDERATED HERMES INC.
FHI
3,452,810
13.350%
3,452,810increase
(New Position)
Filing
History
2020-12-10
4:51 pm
Sale
2020-12-08 13D Arcturus Therapeutics Holdings Inc.
ARCT
Ultragenyx Pharmaceutical Inc.
RARE
2,200,000
9.000%
-800,000decrease
(-26.67%)
Filing
History
2020-10-09
1:41 pm
Purchase
2020-03-31 13G Arcturus Therapeutics Holdings Inc.
ARCT
ARK Investment Management LLC 2,495,842
10.230%
2,495,842increase
(New Position)
Filing
History
2020-09-11
4:00 pm
Purchase
2020-09-01 13G Arcturus Therapeutics Holdings Inc.
ARCT
HealthCor Management L.P. 1,584,466
6.500%
1,584,466increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2